Q32 Bio (QTTB) Revenue Growth (5y) (2023)

Q32 Bio (QTTB) Revenue Growth (5y) (2023) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,861.65 Bn	66,861.36 Bn	-
2	Nanobiotix	1,910.87 Bn	1,910.81 Bn	-
3	Akari Therapeutics	989.71 Bn	989.71 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.90 Bn	61.14 Bn	3.31 Bn
7	Belite Bio	62.74 Bn	62.74 Bn	-
8	Argenx Se	55.83 Bn	50.65 Bn	1.41 Bn
9	Revolution Medicines	37.46 Bn	37.46 Bn	-
10	Q32 Bio	216.50 Mn	165.75 Mn	-

Download Data